Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Polyamyna

Polyamyna
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Provider of antimicrobial additives intended to provide protection against multi-drug resistant bacteria. The company's products include advanced coatings and paints that are compatible with a range of surfaces and polymers and are robust, permanent, non-toxic and economical, could be effectively used against multidrug and pan-drug resistant bacteria which when added to food-packaging polymers kills the bacteria and creates a barrier for O2, CO2 and other vapor by forming a tortuous path, enabling food packaging industries to prevent healthcare associated infections.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Services
Primary Office
  • 230 Elizabeth Avenue
  • Saint John's, Newfoundland and Labrador A1C 5S7
  • Canada

+1 (709) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Polyamyna’s full profile, request a free trial.

Polyamyna Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 17-Nov-2017 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Polyamyna Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Genesis Centre Accelerator/Incubator 000 0000 000000 0

Polyamyna Executive Team (1)

Name Title Board
Seat
Contact
Info
Frank Schweizer Ph.D Executive